Revenue
83.7 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 83699000 USD Source
Annual consolidated revenue for 2025: about USD 283.1M, using the latest reported figures. The previous period, 2024, was about USD 235.1M.
83.7 million USD
2026 Q3 · USD
42.25%
2026 Q3 · %
46.4 million USD
2026 Q3 · USD
45792000 USD
133995000 shares
1.63% · 2.15 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
322 million USD
2025-10-01 – 2026-09-30
314 million USD
2025-10-01 – 2026-09-30
177 million USD
2025-10-01 – 2026-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-30.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 235.13 million
–
Current period
USD 283.06 million
–
283055000 − 235133000 = 47922000 USD
235133000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source283055000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 5.75 million
–
Current period
USD 287.2 million
–
287202000 − 5752000 = 281450000 USD
5752000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source287202000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 44.39 million
–
Current period
USD 135.66 million
–
135658000 − 44388000 = 91270000 USD
44388000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source135658000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 173000 | 25200000 Derived | -25027000 | Unavailable | Unavailable | -18728000 Derived | Source
|
| 2017 2017-01-01 – 2017-12-31 | 418000 | 47286000 Derived | -46868000 | Unavailable | Unavailable | -41194000 Derived | Source
|
| 2018 2018-01-01 – 2018-12-31 | 463000 | 55703000 Derived | -55240000 | -2161000 Derived | -53079000 | -51641000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 318000 | 91261000 Derived | -90943000 | -2558000 Derived | -88385000 | -63672000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 50118000 | 154408000 Derived | -104290000 | -1610000 Derived | -102680000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 45605000 | 226340000 Derived | -180735000 | 231000 Derived | -180966000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 134030000 | 245500000 Derived | -111470000 | -3290000 Derived | -108180000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 175513000 | 267204000 Derived | -91691000 | -13671000 Derived | -78020000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 235133000 | 239820000 Derived | -4687000 | -10439000 Derived | 5752000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 283055000 | 178141000 Derived | 104914000 | -182288000 Derived | 287202000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 173000 |
|
| 2017 | Revenue | 418000 |
|
| 2018 | Revenue | 463000 |
|
| 2019 | Revenue | 318000 |
|
| 2020 | Revenue | 50118000 |
|
| 2021 | Revenue | 45605000 |
|
| 2022 | Revenue | 134030000 |
|
| 2023 | Revenue | 175513000 |
|
| 2024 | Revenue | 235133000 |
|
| 2025 | Revenue | 283055000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | 141.6% |
|
| 2018 | Year over year | 10.8% |
|
| 2019 | Year over year | -31.3% |
|
| 2020 | Year over year | 15,660.4% |
|
| 2021 | Year over year | -9% |
|
| 2022 | Year over year | 193.9% |
|
| 2023 | Year over year | 31% |
|
| 2024 | Year over year | 34% |
|
| 2025 | Year over year | 20.4% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -14,466.5% |
|
| 2017 | Operating margin | -11,212.4% |
|
| 2018 | Operating margin | -11,930.9% |
|
| 2019 | Operating margin | -28,598.4% |
|
| 2020 | Operating margin | -208.1% |
|
| 2021 | Operating margin | -396.3% |
|
| 2022 | Operating margin | -83.2% |
|
| 2023 | Operating margin | -52.2% |
|
| 2024 | Operating margin | -2% |
|
| 2025 | Operating margin | 37.1% |
|
| 2016-12-31 | Net margin | Not reported |
|
| 2017-12-31 | Net margin | Not reported |
|
| 2018 | Net margin | -11,464.1% |
|
| 2019 | Net margin | -27,794% |
|
| 2020 | Net margin | -204.9% |
|
| 2021 | Net margin | -396.8% |
|
| 2022 | Net margin | -80.7% |
|
| 2023 | Net margin | -44.5% |
|
| 2024 | Net margin | 2.4% |
|
| 2025 | Net margin | 101.5% |
|
| 2016 | Free cash flow margin | -10,825.4% |
|
| 2017 | Free cash flow margin | -9,855% |
|
| 2018 | Free cash flow margin | -11,153.6% |
|
| 2019 | Free cash flow margin | -20,022.6% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -18713000 |
|
| 2017 | Operating cash flow | -41169000 |
|
| 2018 | Operating cash flow | -51611000 |
|
| 2019 | Operating cash flow | -63585000 |
|
| 2020 | Operating cash flow | -69858000 |
|
| 2021 | Operating cash flow | -157692000 |
|
| 2022 | Operating cash flow | -79529000 |
|
| 2023 | Operating cash flow | -33461000 |
|
| 2024 | Operating cash flow | 44388000 |
|
| 2025 | Operating cash flow | 135658000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | -18728000 |
|
| 2017 | Free cash flow | -41194000 |
|
| 2018 | Free cash flow | -51641000 |
|
| 2019 | Free cash flow | -63672000 |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 36.9% |
|
| 2017 | Liabilities / assets | 12.7% |
|
| 2018 | Liabilities / assets | 22.8% |
|
| 2019 | Liabilities / assets | 7.9% |
|
| 2020 | Liabilities / assets | 12.1% |
|
| 2021 | Liabilities / assets | 11.8% |
|
| 2022 | Liabilities / assets | 13.9% |
|
| 2023 | Liabilities / assets | 31% |
|
| 2024 | Liabilities / assets | 31.4% |
|
| 2025 | Liabilities / assets | 22.7% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 5.22× |
|
| 2017 | Current assets / current liabilities | 21.5× |
|
| 2018 | Current assets / current liabilities | 18.3× |
|
| 2019 | Current assets / current liabilities | 27.9× |
|
| 2020 | Current assets / current liabilities | 13.11× |
|
| 2021 | Current assets / current liabilities | 12.63× |
|
| 2022 | Current assets / current liabilities | 9.6× |
|
| 2023 | Current assets / current liabilities | 5.5× |
|
| 2024 | Current assets / current liabilities | 4.57× |
|
| 2025 | Current assets / current liabilities | 5.25× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | Unavailable Not reported for this period. | −USD 18.71 million Exact valueExact value: -18713000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 15,000 Exact valueExact value: 15000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.73 million Calculation and evidence-18713000 − 15000 USD Exact free cash flow: -18728000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | Unavailable Not reported for this period. | −USD 41.17 million Exact valueExact value: -41169000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 25,000 Exact valueExact value: 25000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 41.19 million Calculation and evidence-41169000 − 25000 USD Exact free cash flow: -41194000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 53.08 million Exact valueExact value: -53079000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 51.61 million Exact valueExact value: -51611000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 30,000 Exact valueExact value: 30000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 51.64 million Calculation and evidence-51611000 − 30000 USD Exact free cash flow: -51641000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 88.39 million Exact valueExact value: -88385000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.59 million Exact valueExact value: -63585000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 87,000 Exact valueExact value: 87000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.67 million Calculation and evidence-63585000 − 87000 USD Exact free cash flow: -63672000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 102.68 million Exact valueExact value: -102680000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 69.86 million Exact valueExact value: -69858000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 180.97 million Exact valueExact value: -180966000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 157.69 million Exact valueExact value: -157692000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 108.18 million Exact valueExact value: -108180000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 79.53 million Exact valueExact value: -79529000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 78.02 million Exact valueExact value: -78020000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.46 million Exact valueExact value: -33461000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | USD 5.75 million Exact valueExact value: 5752000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 44.39 million Exact valueExact value: 44388000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 287.2 million Exact valueExact value: 287202000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 135.66 million Exact valueExact value: 135658000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
241 filings · 2,248 latest values · 2,248 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001600620, 1600620, AUPH, edgar:1600620
Also known as Aurinia Pharmaceuticals Inc.